105 related articles for article (PubMed ID: 6529444)
1. [Binding and activation of the first component of human complement on artificial matrices].
Kozlov LV; Sizoĭ MN; Zinchenko AA; Ivanov AE; Zubov VP
Bioorg Khim; 1984 Dec; 10(12):1629-38. PubMed ID: 6529444
[TBL] [Abstract][Full Text] [Related]
2. [Stepwise dissociation of subcomponents of C1, the first component of human complement, upon activation on an affinity sorbent].
Kozlov LV; Shoĭbonov BB; Ivanov AE; Zubov VP; Antonov VK
Biokhimiia; 1989 Oct; 54(10):1745-51. PubMed ID: 2605275
[TBL] [Abstract][Full Text] [Related]
3. Inorganic supports coated with N-substituted polyacrylamides: application to biospecific chromatography of proteins.
Ivanov AE; Kozlov LV; Shojbonov BB; Zubov VP; Antonov VK
Biomed Chromatogr; 1991 Mar; 5(2):90-3. PubMed ID: 1868265
[TBL] [Abstract][Full Text] [Related]
4. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
Heinz HP; Burger R; Golan MD; Loos M
J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
[TBL] [Abstract][Full Text] [Related]
5. C1q: isolation from human serum in high yield by affinity chromatography and development of a highly sensitive hemolytic assay.
Kolb WP; Kolb LM; Podack ER
J Immunol; 1979 May; 122(5):2103-11. PubMed ID: 109524
[TBL] [Abstract][Full Text] [Related]
6. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
7. Influence of aggregate size on the binding and activation of the first component of human complement by soluble IgG aggregates.
Doekes G; Vanes LA; Daha MR
Immunology; 1982 Apr; 45(4):705-13. PubMed ID: 7068172
[TBL] [Abstract][Full Text] [Related]
8. The first component of complement. I. Purification and properties of native C1.
Medicus RG; Chapuis RM
J Immunol; 1980 Jul; 125(1):390-5. PubMed ID: 7381205
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
[TBL] [Abstract][Full Text] [Related]
10. C1q binding and C1 activation by various isolated cellular membranes.
Storrs SB; Kolb WP; Olson MS
J Immunol; 1983 Jul; 131(1):416-22. PubMed ID: 6602834
[TBL] [Abstract][Full Text] [Related]
11. Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.
Beebe DP; Schreiber RD; Cooper NR
J Immunol; 1983 Mar; 130(3):1317-22. PubMed ID: 6822737
[TBL] [Abstract][Full Text] [Related]
12. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
[TBL] [Abstract][Full Text] [Related]
13. Activation of C1 by soluble IgG aggregates as detected by a novel one-step hemolytic assay that specifically measures the proenzyme form of C1s.
Doekes G; van Es LA; Daha MR
J Immunol; 1983 Oct; 131(4):1924-9. PubMed ID: 6604753
[TBL] [Abstract][Full Text] [Related]
14. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus.
Butko P; Nicholson-Weller A; Wessels MR
J Immunol; 1999 Sep; 163(5):2761-8. PubMed ID: 10453019
[TBL] [Abstract][Full Text] [Related]
15. A mutant human IgG molecule with only one C1q binding site can activate complement and induce lysis of target cells.
Michaelsen TE; Thommesen JE; Ihle O; Gregers TF; Sandin RH; Brekke OH; Sandlie I
Eur J Immunol; 2006 Jan; 36(1):129-38. PubMed ID: 16323243
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin binds C1q and activates the classical pathway of complement.
Peake PW; Shen Y; Walther A; Charlesworth JA
Biochem Biophys Res Commun; 2008 Mar; 367(3):560-5. PubMed ID: 18179772
[TBL] [Abstract][Full Text] [Related]
17. Interaction between Schistosoma mansoni and the complement system: binding of C1q to schistosomula.
Santoro F; Ouaissi MA; Pestel J; Capron A
J Immunol; 1980 Jun; 124(6):2886-91. PubMed ID: 6989909
[TBL] [Abstract][Full Text] [Related]
18. Interaction between Schistosoma mansoni and the complement system: role of IgG Fc peptides in the activation of the classical pathway by schistosomula.
Ouaissi MA; Auriault C; Santoro F; Capron A
J Immunol; 1981 Oct; 127(4):1556-9. PubMed ID: 7024409
[TBL] [Abstract][Full Text] [Related]
19. Studies on the haemolytic activity of circulating C1q-C3/C4 complexes.
Wouters D; Brouwer MC; Daha MR; Hack CE
Mol Immunol; 2008 Apr; 45(7):1893-9. PubMed ID: 18054386
[TBL] [Abstract][Full Text] [Related]
20. The relationship between the binding ability and the rate of activation of the complement component C1.
Folkerd EJ; Gardner B; Hughes-Jones NC
Immunology; 1980 Sep; 41(1):179-85. PubMed ID: 7429549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
